Evidence map›Paper›PMID 41262771›Full record

ReviewDementia & neuropsychologia2025

Inclusive research with individuals with Down syndrome at risk for dementia.

Luciana Mascarenhas Fonseca, Ubiratan Tafuri Queiroz, Miron Tafuri Queiroz, Orestes Vicente Forlenza

Abstract readReview
In one paragraph

Review in Dementia & neuropsychologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Introduction to the special issue on Down syndrome.Dementia & neuropsychologia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Luciana Mascarenhas FonsecaThe Krieger Klein Alzheimer's Research Center, Rutgers Health, New Brunswick, NJ, United States.ORCID https://orcid.org/0000-0002-2849-0545
Ubiratan Tafuri QueirozThe Krieger Klein Alzheimer's Research Center, Rutgers Health, New Brunswick, NJ, United States.
Miron Tafuri QueirozThe Krieger Klein Alzheimer's Research Center, Rutgers Health, New Brunswick, NJ, United States.
Orestes Vicente ForlenzaUniversidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Departamento e Instituto de Psiquiatria, Laboratório de Neurosciência, São Paulo SP, Brazil.ORCID https://orcid.org/0000-0002-6962-5899

Funding

Intraindividual cognitive variability in aging adults with Down syndrome: associations with Alzheimer's disease plasma biomarkers, neuropathology and clinical dementiaR00AG082864 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Luciana Fonseca · 2025 to 2026
$494k
Intraindividual cognitive variability in aging adults with Down syndrome: associations with Alzheimer's disease plasma biomarkers, neuropathology and clinical dementiaK99AG082864 · NIA · WASHINGTON STATE UNIVERSITY · PI FONSECA, LUCIANA · 2023 to 2024
$256k
NIA NIH HHS K99 AG082864NIA NIH HHS R00 AG082864
6 · The paper itself

Abstract

Inclusive research is a relatively new concept that has received attention in recent years as a scientific priority to respond to health disparities and maximize the practical implications of research. This approach involves a partnership between academics and the individuals who are experiencing the problem to be investigated. Despite the high incidence of dementia and asymptomatic Alzheimer's disease in aging individuals with Down syndrome, inclusive research with this population or those with intellectual disability (ID) at risk of dementia is an area that is little approached and not well documented. Here, we describe the evolution of inclusive research on ID and dementia, some of the challenges and benefits of its implementation, and key aspects to consider when planning such studies. There is an urgent need for national and international guidelines to support inclusive research involving this population. Such frameworks should ensure accessibility, ethical rigor, the meaningful participation of co-researchers, ultimately advancing equity and scientific quality in this underrepresented field.

Indexed as

Alzheimer DiseaseCommunity-Based Participatory ResearchDementiaDown SyndromeHealthy EquityIntellectual Disability

Identifiers

PMID41262771
PMCPMC12626224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.